News

Class Action Settlement for InterPrivate Stockholders Announced

Class Action Settlement for InterPrivate Stockholders Announced

Understanding the Proposed Class Action Settlement

Recently, a significant development has emerged regarding a class action settlement that concerns all individuals and entities that purchased, acquired, or held InterPrivate Class A Common Stock. This settlement pertains to transactions occurring between specific dates, and it is essential for investors in this category to become informed. The proposed settlement has been authorized by the court, making it a noteworthy event in the realm of securities litigation.

Who is Affected by This Settlement?

This class action settlement invites all persons and entities who purchased, acquired, or held InterPrivate Class A Common Stock from August 16, 2019, to March 12, 2021, as well as those who held redeemable common stock on March 9, 2021. These individuals and entities are referred to as the "Class Members." It is important to note that participation in the settlement is contingent upon not being excluded from the Class.

The Implications of Class Membership

If you fall under the classification of Class Member, you may have legal rights affected by ongoing proceedings within the corresponding litigation. Importantly, the completion of a valid proof of claim and release form is necessary to ensure potential recovery from the proceeds of the settlement.

Key Deadlines and Requirements

To maximize your potential distribution from the settlement funds, a proof of claim must be submitted by mail, postmarked or received by September 11, 2025, or electronically via a designated website by the same date. Failing to do so means you may risk rejection of your claim and miss out on your entitled share from the settlement.

The Hearing Date

A major court hearing is scheduled for September 12, 2025, at 1:30 p.m. ET, presided over by Judge Lori W. Will at the Court of Chancery. During this hearing, the court will assess the proposed settlement's fairness, whether it should be approved, and the associated attorneys' fees and expenses.

Background on the Class Action

The consolidated class action arises from claims alleging that certain individuals violated their fiduciary duties to shareholders of InterPrivate Acquisition Corp. This includes claims about misleading proxy solicitation materials that purportedly impaired shareholders' rights. The defendants, however, deny all wrongdoing associated with these claims.

Your Right to Object

Class Members also possess the right to object to various aspects of the settlement, including the proposed plan of allocation and attorney fees. Any objections must be filed with the court and served to both Plaintiffs' and Defendants' counsel by August 21, 2025. The Class is classified as a non-opt-out settlement class, indicating that Class Members cannot exclude themselves from participation.

Additional Information and Inquiries

Should you require further clarification or wish to obtain additional documentation pertinent to the settlement, you can reach out directly to the law firms involved. The Robbins Geller Rudman & Dowd LLP and Grant & Eisenhofer P.A. are representing the interests of the Class Members. They can provide details regarding the settlement, the claims process, and any necessary forms. Please avoid directing inquiries to the court or the defendants on matters concerning the settlement.

As this process unfolds, it's crucial for affected shareholders to stay informed and act within the stipulated timeframes. Your rights as a Class Member in this settlement process could hold significant implications for your financial standing.

Frequently Asked Questions

What is the purpose of this settlement?

The settlement is intended to resolve claims against the defendants relating to their alleged fiduciary duty violations and to provide compensation to affected shareholders of InterPrivate.

How do I know if I am a Class Member?

If you purchased, acquired, or held InterPrivate Class A Common Stock during the specified dates and held redeemable common stock on the qualifying date, you are likely a Class Member.

What do I need to do to claim my share?

You must submit a valid proof of claim and release form by the deadline to be eligible for any distribution from the settlement funds.

Is there a fee for submitting a proof of claim?

No, there should not be a fee for submitting your proof of claim; however, ensure that all forms are completed correctly to prevent rejection.

Can I object to the settlement?

Yes, Class Members have the right to object to the settlement, and these must be filed with the court and served to the involved parties by the specified deadline.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BIBIBOP Brings Good Vibes with OLIPOP Happy Hour

Updated Category News Views 131

Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 97

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 169

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
Cardinal Infrastructure Faces Legal Scrutiny Amid Losses

Updated Category News Views 125

Cardinal Infrastructure Group Under Intense Investor Scrutiny Well, ain't this a messy soup of financial blunders? Cardinal Infrastructure Group (Nasdaq: CDNL) finds itself on the sharp end of a potential securities law investigation, thanks to some colossal screw-ups in managing project costs and estimates. Investors are rightly pissed after the company's shares...

Continue Reading
Biointron's RushDATA™: Speeding Up Antibody Discovery

Updated Category News Views 227

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 137

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 108

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 219

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Purdue's xGTT: Pioneering a New Trust Standard in Tech

Updated Category News Views 150

A Bold New Benchmark in Tech Trust You've got to hand it to the folks at Purdue's Krach Institute—they're not dancing around the fringes but diving straight into the thick of it with their Global Trusted Tech Standard, or xGTT. This isn't just another checkbox for compliance nerds. The xGTT is all about building trust in technology that's woven with democratic values...

Continue Reading

Top 5 Most Recently Viewed Articles

HawkEye 360 Expands Capabilities with Strategic NRO Partnership

Updated Category News Views 189

HawkEye 360's New Partnership with the NRO HawkEye 360, recognized as a leader in sharing signals intelligence data and analytics, has recently secured a significant funding extension from the National Reconnaissance Office (NRO) alongside the Commercial Systems Program Office (CSPO). This collaborative effort is set to span over 23 months, aiming to enhance the...

Continue Reading
Consumer Sentiment and Its Impact on Economic Reflation Trends

Updated Category News Views 88

Understanding Consumer Sentiment Trends In recent discussions, we have explored how indicators like inflation gauges can influence economic forecasts. A notable aspect is consumer sentiment, which provides insights into spending behaviors and overall market confidence. Recent readings suggest a surprising optimism among consumers, especially in light of complex inflation...

Continue Reading
Ocular Therapeutix Announces Major Stock Offering Ahead of Trials

Updated Category News Views 264

Ocular Therapeutix's Strategic Stock Offering Announcement Ocular Therapeutix, Inc. (Nasdaq: OCUL), known for its commitment to enhancing retinal health, has declared an exciting new chapter in its journey. The company has recently confirmed the pricing for an underwritten public offering of 37,909,018 shares of its common stock, set at $12.53 per share. This significant...

Continue Reading
Roku Ads Manager: Innovations for Today’s Marketing Landscape

Updated Category News Views 145

Roku Unveils Ads Manager for Growth-Driven Marketers Roku (NASDAQ: ROKU) has stepped up its game in the streaming industry by launching a new platform named Roku Ads Manager. This self-service tool is tailored specifically for marketers eager to improve their connected television (CTV) campaigns. The rollout of this innovative platform comes as advertising trends shift...

Continue Reading
Evaxion Secures $10.8 Million in Strategic Public Offering

Updated Category News Views 97

Evaxion Biotech's Recent Public Offering Evaxion Biotech A/S (NASDAQ: EVAX) has recently made headlines with its announcement of a public offering. The company, renowned for its pioneering work in AI-Immunology™, has set the offering's combined public price at $2.71 per ADS, with warrants allowing the purchase of equal representation. This promising move emphasizes...

Continue Reading